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Allan Mayaba Mwiinde1,6*, Martin Simuunza1, Boniface Namangala1, Chitalu Miriam Chama-Chiliba2,
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Abstract
Background: Acute human African trypanosomiasis (rHAT) caused by Trypanosoma brucei rhodesiense is associated
with high mortality and is fatal if left untreated. Only a few studies have examined the psychological, social
and economic impacts of rHAT. In this study, mixed qualitative and quantitative research methods were used
to evaluate the socio-economic impacts of rHAT in Mambwe, Rufunsa, Mpika and Chama Districts of Zambia.
Methods: Individuals diagnosed with rHAT from 2004 to 2014 were traced using hospital records and
discussions with communities. Either they, or their families, were interviewed using a structured questionnaire
and focus group discussions were conducted with affected communities. The burden of the disease was
investigated using disability adjusted life years (DALYs), with and without discounting and age-weighting. The
impact of long-term disabilities on the rHAT burden was also investigated.
Results: Sixty four cases were identified in the study. The majority were identified in second stage, and the
mortality rate was high (12.5%). The total number of DALYs was 285 without discounting or age-weighting.
When long-term disabilities were included this estimate increased by 50% to 462. The proportion of years
lived with disability (YLD) increased from 6.4% to 37% of the undiscounted and un-age-weighted DALY total.
When a more active surveillance method was applied in 2013–2014 the cases identified increased dramatically, suggesting
a high level of under-reporting. Similarly, the proportion of females increased substantially, indicating that passive
surveillance may be especially failing this group.
An average of 4.9 months of productive time was lost per patient as a consequence of infection. The health consequences
included pain, amnesia and physical disability. The social consequences included stigma, dropping out of education, loss of
friends and self-esteem. Results obtained from focus group discussions revealed misconceptions among community
members which could be attributed to lack of knowledge about rHAT.
(Continued on next page)
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Conclusions: The social and economic impact of rHAT on rural households and communities is substantial. Improved
surveillance and strengthening of local medical services are needed for early and accurate diagnosis. Disease prevention
should be prioritised in communities at risk of rHAT, and interventions put in place to prevent zoonotic disease spill over
from domestic animals and wildlife. Supportive measures to mitigate the long-term effects of disability due to rHAT are
needed.
Keywords: Human African trypanosomiasis, Hat, Sleeping sickness, T. B. Rhodesiense, Social and economic
burden, DALYs, Zambia
Multilingual abstract
Please see Additional file 1 for translation of the abstract
into the five official working languages of the United
Nations.
Background
Human African trypanosomiasis (HAT), or sleeping
sickness, is a vector-borne neglected tropical disease
(NTD) caused by two morphologically indistinguishable
trypanosome species, Trypanosoma brucei gambiense
(western and central Africa) and Trypanosoma brucei
rhodosiense (eastern and southern Africa), spread by
tsetse flies (Glossina ssp) [1]. Trypanosoma brucei
gambiense is transmitted through human-tsetse contact
and is responsible for the majority of the reported cases
[2] while T. b. rhodesiense is a complex zoonotic disease
involving a wide range of wildlife and livestock reser-
voirs [1, 3]. Although the two sub-species of Trypano-
soma brucei are morphologically indistinguishable, they
can be differentiated by molecular methods [4]. HAT is
invariably fatal if left untreated with death occurring
between six to eight months in the case of the acute
Rhodesian form (rHAT) or after one or more years in
the case of the chronic Gambian form (gHAT) [5].
The early febrile stage for both diseases includes a
variety of non-specific sequelae (headache, fever, joint
pains, chancre, skin lesion, pruritus and a variety of endo-
crine, cardiac and gastrointestinal disorders), while the late
neurological stage is characterised by walking difficulties,
sensory disorders, tremors, sleeping disturbances, coma
and other related symptoms [6, 7]. Drug therapies for both
early and late stage rHAT have severe and debilitating
adverse side-effects; in particular, administration of the
arsenic-based drug melarsoprol in late stage rHAT causes
encephalopathy in about 5 to 10% of the patients [6].
Approximately 70 million people are at varying degrees
of risk from HAT in sub-Saharan Africa with an estimated
21 million living in areas with a moderate to very high risk
of infection [8]. HAT has been a major impediment to
social and economic development in most sub-Saharan
African rural communities, mainly affecting the poorest
people in remote rural areas. Based on the disability-
adjusted -life year, or DALY (an estimate of the number of
years of life lost due to premature death and disability),
HAT is estimated to cause approximately 1.6 million
DALYs, and is considered second among all vector-borne
diseases in Africa for mortality and fourth for related dis-
ability [9]. While the DALY has become a ubiquitous
metric in global health, important limitations exist in
relation to the DALY and HAT [6, 10]. These include the
specific disability weights given, accounting for undetected
cases and the exclusion of long-term impacts on growth
and neurological impairment, either by infection or drug
toxicity. While over 175,000 cases of HAT were reported
between 2000 and 2009 [11], the disease is found largely
in remote rural areas with limited diagnostic capacity and
poor access to health facilities [12, 13]. According to the
World Health Organization (WHO), in 2009 about half of
cases were thought to be unreported [14]. Due to sus-
tained control activities (in particular active case-finding
for gHAT) this represented a significant improvement on
the situation in the late 1990s when only just over 10% of
all HAT cases were reported [14]. In 2009 the total num-
ber of reported cases fell below 10,000 for the first time in
five decades, by 2015 fewer than 3000 cases were reported,
of which 97% were gHAT. However, for rHAT there has
been limited active case-finding, so that it is difficult to
gauge the level of under-reporting.
The few available district-level DALY studies for HAT
have confirmed its significant public health burden in
endemic communities [15, 16]. Costs incurred by HAT
patients have been calculated in Uganda, Tanzania and
the Democratic Republic of Congo (DRC), showing that
the disease causes a significant impact on households
and health systems [15–17]. Patient expenses at a HAT
treatment centre in Tanzania were estimated at US$
68.40 for indirect medical costs (transport and living
expenses) and US$ 25.50 for direct medical costs while
costs to the local health services were US$ 83.80 per pa-
tient [15]. In the DRC, total treatment costs for gHAT
were equivalent to five months of a household’s income,
rising to as much as 17 months in cases of disease
complications [18]. Health seeking behaviour studies
have shown that HAT patients visit numerous public
and private health providers over several months before
being correctly diagnosed and treated [13, 19, 20].
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Recovery periods typically take many months and HAT
is thought to lead to many long-term disabilities caused
by drug toxicity and infection, although the associated
morbidity has not been quantified [21]. The DALY is not
the only methodology that can be applied to quantify
disease burden; economic calculations are also regularly
used at both societal and household level – for example,
impact of treatment costs and losses in income to
patient households [18].
For many of the NTDs, the burden of disease can also
be approached from the perspective of the individual pa-
tient where infection has significant social, psychological
and livelihood impacts [22–25]. HAT patients mostly
live in poor rural settings and are dependent on subsis-
tence agriculture, wildlife ecosystem services and live-
stock keeping, in the vicinity of tsetse-breeding sites
[15–18]. NTDs such as gHAT and rHAT are considered
major obstacles to socio-economic development, creat-
ing a ‘cycle of poverty’ among affected households, but
few disease burden studies have captured the multiple
ways in which the NTDs affect household productivity,
quality of life and livelihood strategies. Of note, within
the community and family structures, rHAT impacts on
lives and livelihoods [26]. In Zambia, although rHAT is
reported to be in decline [27], sporadic cases of the
disease continue to be reported [28].
While the HAT burden may not appear significant in
comparison to diseases like HIV/AIDS, tuberculosis or
malaria, it is highly focalised and its impact on commu-
nities should be assessed at a local-level. Estimating the
economic and social consequences of the disease at
household level is the best way to accurately ascertain
the impact of the disease, focusing on psychological,
social and economic impacts for the patient, their house-
hold and their community.
This study aimed to assess the economic and social
consequences of HAT at household level in four districts
where rHAT is endemic; tracing the experience of the
household from infection through to treatment path-
ways, coping strategies, livelihood impacts, the process
of diagnosis, rHAT treatment, recovery or disability and
death. This information will assist in the broader policy-
making and prioritisation of interventions necessary to
ease the burden of rHAT in affected areas.
Methods
Description of the study area
Data for this study were collected between September
and November, 2014. The study area comprised of four
districts within Zambia (Rufunsa District in Lusaka
Province, Mpika and Chama Districts in Muchinga
Province, and Mambwe District in Eastern Province)
where sporadic cases of rHAT are reported (Fig. 1) [29].
These areas are predominately rural, where the economy
is based on mixed crop-livestock farming and small-
scale trades. Over 60% of the population is considered to
live below the poverty line, of whom 40% live in absolute
poverty. Farming activities revolve around a variety of
different main crops such as maize, groundnuts, soya
beans, cotton and tobacco, grown during the rainy sea-
son. Wetlands are significant areas for keeping cattle
(herd sizes are in most cases fewer than 80 cattle), while
also facilitating the survival of a low to moderate tsetse
population density. The major ethnic groups include
Bemba and Bisa in Muchinga Province, Chewa, Nsenga,
Tumbuka and Ngoni, in Eastern Province, and Soli in
Lusaka Province.
Study design
Both cross-sectional and retrospective surveys were
undertaken to determine the economic and social conse-
quences of rHAT in previously and currently affected
rHAT patients, with additional focus group discussions.
All patients diagnosed with rHAT from 2004 to 2014 in
Zambia’s Lusaka, Eastern and Muchinga Provinces were
included in the study. Patients diagnosed with HAT
between 2004 and 2012 were identified using passive
surveillance methods using hospital records. In 2013 and
2014 this method was supplemented by a degree of
active surveillance using discussions with local commu-
nities to identify additional patients. Diagnosis was con-
firmed using polymerise chain reaction (PCR) and/or
loop mediated isothermal amplification (LAMP) [27]. In
total there were 64 diagnosed HAT cases. Of these, 22
patients came from Chama, 11 from Rufunsa, 28 from
Mpika and three from Mambwe Districts. All cases
(n = 64) were traced and all patients or their families
were interviewed with at most two visits.
Structured questionnaires were administered to all
patients or their close relatives (care givers) to collect
information on the economic and social impacts of
rHAT in the communities or districts. Hospital re-
cords of patients who were interviewed were re-
trieved, where possible, to confirm the time period
the patient was undergoing treatment. Patient data
were obtained together with national statistics from
the Ministry of Health.
Focus group discussions were also conducted with the
affected communities [30]. The focus groups comprised
seven to ten people per discussion and included health
workers, people who had suffered from rHAT and their
relatives or friends, so as to obtain in-depth information
on concepts, perceptions and ideas of the group regard-
ing the social consequences of the disease. A total of
eight focus group discussions were conducted during the
study, covering all four districts (two in Chama, one in
Mambwe, two in Mpika and three in Rufunsa).
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Data analysis
Focus group discussion data were analysed using in-
ductive approaches and thematic coding, carried out
by two independent researchers. All structured inter-
view data were entered and analysed using Excel
(Microsoft Office Excel® 2007). Qualitative data were
entered into Microsoft Word™ and analysed manually
based on accepted methods of coding and memo-
writing [30, 31]. All transcripts were de-identified and
personal identifiers were removed to protect indivi-
dual patient data. For quantitative data, descriptive
statistics were generated for variables under study,
and analysis of variance (ANOVA) was used to deter-
mine associations among the variables. Significance
was accepted at 95% confidence level for all analyses.
Calculation of DALYs
Disability-adjusted life years were calculated using the
DALY calculation template available through the National
Tools of the WHO’s Global Burden of Disease website
[32]. The template was adapted so that there was one row
per patient in the study, enabling each patient to be
assigned their own disability weight and duration.
Therefore, although in this paper summary figures are
provided by age category for convenience, DALYs were ac-
tually calculated at the individual level. For years of life
lost (YLL), the Population and Deaths per 1000 columns
were left blank. The recorded age at death was entered
into the respective column for each individual as was the
estimated life expectancy at that age (estimated for each
individual using the 2010 Census of Population and Hous-
ing figures for rural life expectancy [33]).
To calculate the years lived with disability (YLD),
the Population column was once again left blank. As
each row corresponded to an individual, an incidence
of 1 was entered into the Incidence column and the
Incidence per 1000 column left blank. For patients
who survived infection with rHAT, the ages at onset
were calculated by subtracting the time elapsing since
diagnosis from the age at interview. For patients who
died, the age at onset was calculated by subtracting
the time elapsing between diagnosis and death from
their age at death. Duration was based on careful
questioning of the patients as to how long they had
been unable to do their normal activities. This was
estimated from the time they first experienced
Fig. 1 Districts with recorded cases of Sleeping Sickness in Zambia, as of 2014. Red = Rufunsa District, orange = Mambwe District, purple = Mpika
District, and blue = Chama District
Mwiinde et al. Infectious Diseases of Poverty  (2017) 6:150 Page 4 of 13
symptoms to the time they resumed productive work.
As some patients were still hospitalised or had not
started their recovery at the time of the interviews,
duration could not be estimated for every patient. For
six patients the duration could not be estimated and
the average duration for the whole cohort was used
instead.
Disability weights of 0.21 and 0.81 were applied for the
duration of illness as described above for first and second
stage rHAT respectively, as described by Fèvre et al. [16].
Notably, the use of these disability weights in the DALY
calculation has the limitation in that it assigns the same
disease weighting to individuals of the same stage of the
disease, but with different severity. These disability
weightings also do not account for long-term sequelae
from rHAT, such as disfigurement, physical disability and
mental impairment. To investigate the influence of these
important consequences of rHAT infection (and treat-
ment) on the DALY estimates, a separate calculation was
conducted using additional disability weights for patients
recorded as suffering from these disabilities. Disability
weights have recently been published in the Global
Burden of Disease Study 2015 for patients suffering from
the long-term effects of trypanosomiasis [34]. Disability
weights of 0.067 for disfigurement due to HAT, and 0.542
for severe motor or cognitive impairment due to HAT,
were recommended. To apply these weights in the current
study, an additional row was created in the template
spreadsheet for all patients who had not fully recovered. A
disability weight of 0.067 was applied to all patients who
recovered with a minor disability and a weight of 0.542
was applied to those who recovered with a major physical
or mental disability (note that this was in addition to the
standard disability weights described above). The date of
onset was taken as being the date they were no longer ab-
sent from work (i.e. when the duration for the acute illness
used in the standard DALY calculation ended) and the
condition was assumed to be lifelong.
Alongside the standard DALY calculations, DALYs were
also calculated with the application of discounting (using
a standard rate of 0.03), age-weighting (K = 1 on the
WHO template) and both discounting and age-weighting
[35]. Discounting aligns with empirical economic evidence
[36, 37], in assigning a higher weight to years lost now or
in the near future, as compared to years lost in the more
distant future [37]). The non-discounted, non-age-
weighted DALY estimate is non-discriminatory for age
and was adopted as the baseline method for calculation of
DALYs for males and females [38].
Income
A comprehensive estimate of total household income in-
cluding subsistence farming was outside the scope of this
study. Instead, the focus was on estimating household
resources for spending on health care, by getting informa-
tion on cash income, loans and extra sales of agricultural
produce used to finance the costs of treatment for rHAT.
The currency used during the study period was the United
States Dollar (US$), with an exchange rate of 6.3 Zambian
Kwacha (ZMW) to one US$.
Results
Descriptive statistics
Of the 64 patients that were included in the study, there
were significantly (P < 0.001) more males 45 (70%) than
females 19 (30%). The age distribution of the patients
ranged from 1 to 72 years, with a mean of 29 years
(Fig. 2). Most rHAT patients, 46 (72%) were married, 15
(23%) were single, while only 3 % were widowed. More
than half of the patients, 35 (55%) were peasant farmers
who grew maize, groundnuts and tobacco.
Health-seeking behaviour was relatively poor among
the rHAT patients (Table 1). Thirty one (48%) of the
patients sought medical care from a health facility when
they first developed signs and symptoms of rHAT. How-
ever, 17 (26%) did not seek medical care when they had
developed symptoms of rHAT and did not associate the
intermittent headache initially experienced as a serious
health problem. One patient from Mambwe District be-
lieved they had contracted rHAT in 2011 and sought
care for more than two years from Kamoto Mission
Hospital. The patient was referred to Chipata General
Hospital, where rHAT was consistently misdiagnosed,
until second stage rHAT was diagnosed in 2014. At this
stage the patient was exhibiting impaired judgement and
was experiencing sleeping disorders and intermittent
headaches. In addition, patients with delayed rHAT diag-
nosis felt that going to the health centre would be a
waste of time and had hoped to recover with self-
medication and home-based care as evidenced by the
extract from one patient in Mambwe District:
“I think I have not gotten any help needed in all the
hospitals I have attended. In my opinion they don’t
know what I am sick of. For this reason, I have decided
not to continue seeking medication, but to stay with my
disabilities of sleeping disorders, than going back to the
hospital where they will just watch me and later tell me
to go back home.” Patient, Mambwe District.
Six (9%) of the patients in this study reported to have
sought help from traditional healers before seeking
modern medical attention (including one patient who
also self-medicated). In some areas, there were suspi-
cions from family, relatives, neighbours and friends that
these rHAT patients had been bewitched. The evidence
from the focus group discussions established that going
to the traditional healers for medication was culturally
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important and difficult to neglect in rural settings that
promote the values of traditional healing. However, see-
king treatment from traditional healers incurred high in-
direct costs at household level. Family members
routinely sacrificed animals or agricultural products as a
coping mechanism to meet the costs associated with
seeking medical assistance from traditional healers. On
average, we estimated that an individual would spend
$63.49 for the medical services of traditional healers.
The cost estimate was obtained by using the approxi-
mate market value of the in-kind payments that patients
indicated as having paid for the services. This was be-
cause none of the patients who sought interventions
from traditional healers could recall the exact total costs
of items given in exchange for the traditional medicines,
partly due to lapse of time. It was mentioned in a focus
group discussion that traditional healers were perceived
as taking economic advantage of their clients; consult-
ing, diagnosing, prescribing and searching for traditional
herbs were considered expensive constraints. When
money was unavailable, payments in kind of livestock
(chickens, goats, pigs and cattle) were offered cover
these costs.
At least six (9%) rHAT patients self-medicated prior
to seeking treatment at the health centres, resulting
in delays in cases seeking proper medical care and a
late rHAT diagnosis. The average estimated costs of
self-medication were US$ 98.10 per patient.
Household cash income earned by rHAT patients
The gross cash income earned by rHAT patient house-
holds when in normal health was determined (Table 2).
The median income earned was highest in Chama
District (US$ 63.2), while patients from Mpika earned
the lowest (US$ 15.6). There was significant difference
in the mean income of rHAT patients among the
districts (P < 0.05), with patients from Chama earning
significantly more income than those from Mpika
(P = 0.019).
Indirect costs borne by patients
The indirect costs faced by rHAT patients were consid-
erable (Table 3). These include transport, meals, washing
soap, additional food and other materials required by the
care-giver and patient. In Mpika District, indirect costs
were lower because patients had to walk from their rural
health centre to Chilonga Mission Hospital. The average
cost of transport was calculated for all the four districts
combined. The average amount of money that inter-
viewees reported spending on patient’s transport to and
from a health centre was US$ 99.3, averaged over all the
districts. The amount spent on meals varied depending
on the number of days the patient stayed in the hospital.
Fig. 2 Age distribution of patients included in the study. Mean age = 31.4 years, SD = 14.08
Table 1 Health seeking behaviour of HAT patients when they
first felt ill
Action by patient Number of patients Percent
Went to the clinic 31 48
Self-medication 2 3
Went to traditional healer 5 8
Did nothing 17 26
No action and clinic visit 2 3
Self-medication and clinic visit 5 8
Healer and self-medication 1 2
No reply 1 2
Total 64 100
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The average amount was estimated at US$ 66.5 per
month (in addition to food provided by the hospital
which in most cases was not sufficient). In addition, an
average of US$ 21.4 was spent on other expenditure
such as washing paste, washing soap, toilet paper,
bathing basins and additional food.
Treatment costs
The patients who self-medicated, either sought treat-
ment from traditional healers or were misdiagnosed at
health centres, incurred substantial treatment costs aver-
aging US$ 71.9 before being definitively diagnosed. Pa-
tients living in rural areas sold agricultural products
such as livestock and cereals to sell and cater for medi-
cation (11 households, average amount US$ 302.2).
Period of lost income and household coping mechanisms
The monthly cash income per rHAT patient household
ranged from US$ 4.8 to US$ 1111.1 (Table 2). The
lowest number of months an individual would lose if
diagnosed with rHAT was one month and the highest
36 months (average 4.9 months). Of the 33 households
who spent money, the average spend was 4.5 months of
household cash income. Within this, there was a lot of
variation, with the median spend being 1.3 months.
Three patients, all from Rufunsa, spent 21.0, 22.5 and
23.3 months’ of the whole household’s cash income on
treatment costs, and two others spent 17.0 and
18.3 months’ cash income. Eight of 64 households had
to borrow from other family members or the community
in order to get the financial resources for treatment of a
family member with rHAT. Six of the eight recovered
rHAT patients had settled their debt at the time of inter-
views while two had not.
Disability adjusted life years
Baseline DALY estimates without age-weighting or
discounting are presented in Table 4. The total DALY
estimate for this cohort of patients, without the inclu-
sion of long-term disabilities, was 285.2. YLLs accounted
for the majority, with YLDs accounting for only 6.4%.
Male patients accounted for the majority of DALYs
(231.6) with female patients accounting for much less
(53.6). When long-term disabilities were included in the
calculation, the DALY estimate for the cohort of patients
increased to 426.2, an increment of 49.5%. The propor-
tion of YLDs also increased significantly to 37.4%, an 8.7
fold increment. When age-weighting was applied (ex-
cluding long-term disabilities), the total DALYs for the
patient cohort increased from 285.2 to 336.1 (Table 5).
When discounting was applied as well, this total reduced
to 221.5. If the long-term disabilities were included, the
total DALYs increased from 426.2 to 505.8, a total which
reduced to 319.2 if discounting was applied as well.
Social consequences of human African Trypanosomiasis
The patients whose first diagnosis was not correct, or
when the cause for the disease suffered was not known,
Table 2 Patients’ monthly household gross cash income by district
District Number of patients Median US$ Inter-quartile range US$ Minimum US$ Maximum US $
Chamaa 22 63.2 31.8–174.6 10.3 1111.1
Mambweb 3 31.8 – 31.8 39.7
Mpika 28 15.6 9.9–17.5 4.8 79.4
Rufunsac 10 39.7 15.9–17.4 9.5 317.5
Total 63 63.2 15.4–63.5 4.8 1111.1
a One household had a monthly income of $ 1111.11, excluding this outlier would have reduced the average income for Chama to $161.7 and for the whole
dataset to $61.2. For the whole dataset, 10 households had incomes over $100, of these 5 were over $300 and 8 were in Chama District and 2 in Rufunsa, thus
none in Mambwe or Mpika
b No interquartile range is presented for Mambwe as there were only 3 patients
c Household cash income could not be obtained for one patient
Table 3 Patients’ costs incurred during hospitalisation
Type of expenditure Total spent by whole
patient cohort (US$)
Number of respondents
spending on that category
Percentage of the
whole patient cohort
Average spent
per patient (US$)a
Transport 2980.1 30 47 99.3
Medication 504.1 6 9 84.0
Meals 1729.3 26 41 66.5
Washing paste 80.3 12 19 6.7
Food 117.6 8 13 14.7
Total 5411.3 33 52 164.0
a Average of those patients who spent money on this category, not of the whole patient cohort
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they experienced stigmatization. In particular, some
cases presenting with symptoms of second stage rHAT
were suspected to be HIV positive, especially when
the clinical signs involved mental disorder and/ or
paralysis. Cognitive impairment was associated with
meningitis, encephalitis and depression in these
communities (common symptoms for HIV). In most
cases, individuals feared to be tested for rHAT, lest
they were found to be HIV positive. In a focus
group discussion in Nabwalya community members
stated that:
“There are people whom we have seen who have the
problem of sleeping. At times, they complain of
headache. However, people fear to go to the hospital to
have their blood tested, because they are afraid of being
taken to have HIV/AIDs. Many would prefer staying at
home and doing self-medication or seek traditional
treatment than going to the hospital. When you mention
to them that they are sick, they get annoyed”.
Most rHAT cases (86%) were from remote places
where belief in witchcraft was common. Focus group
discussions indicated that patients who were hallucin-
ating, and who were involved in charcoal burning,
were suspected to have been bewitched (they were accused
of having stolen the wood used for making charcoal).
One patient was perceived to be short tempered,
especially when intoxicated with alcohol. Two-thirds
of school-age children (ages 8–17 years) who had re-
covered from rHAT (n = 9) dropped out of school
because of lack of concentration in class. They were
considered dull witted and as failures by parents and
friends. rHAT cases who were being trained as
Zambia Wildlife Authority Officers were stigmatised
and considered to be lazy when they failed to recover
after being given medication for other ailments:
“There are so many of these situations. One of them
was our wildlife scout (game ranger) student who
we thought had malaria because they could not
find the problem at the hospital. After undergoing
malaria treatment and he was not recovering, we
thought it’s a straight forward case of HIV/AIDs. He
was excluded from the training and considered a
failure. Later on we heard that he died and the
Table 5 Summary of disability adjusted life year calculations with discounting and age-weighting
Excluding LTDs Including LTDs
Study age
group
Age-weighted
DALYs
Discounted
DALYs
Age-weighted,
discounted DALYs
Age-weighted
DALYs
Discounted
DALYs
Age-weighted,
discounted DALYs
Males
≤ 10 0.6 1.0 0.6 42.1 16.8 20.7
11–20 0.2 0.1 0.2 3.8 1.7 2.3
21–30 183.7 93.7 120.7 224.5 113.1 145.9
31–40 41.3 23.8 28.9 55.6 32.0 38.5
41–50 34.5 23.6 25.7 52.4 35.9 38.1
51–60 1.4 1.3 1.4 1.4 1.3 1.4
61–70 0.0 0.0 0.0 0.0 0.0 0.0
71–80 5.8 8.6 5.1 5.8 8.6 5.1
Males total 267.5 152.0 182.5 385.6 209.4 252.1
Females
≤ 10 0.2 0.3 0.2 5.0 2.1 2.5
11–20 66.7 27.5 37.1 106.0 42.9 58.0
21–30 1.1 0.7 1.1 7.3 3.8 5.0
31–40 0.2 0.1 0.2 0.2 0.1 0.2
41–50 0.4 0.3 0.4 1.8 1.5 1.4
51–60 0.0 0.0 0.0 0.0 0.0 0.0
61–70 0.0 0.0 0.0 0.0 0.0 0.0
71–80 0.0 0.0 0.0 0.0 0.0 0.0
Females total 68.6 29.0 39.0 120.3 50.5 67.1
Total 336.1 181.0 221.5 505.8 259.9 319.2
LTDs long term disabilities
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cause of death was sleeping sickness” (ZAWA
Officers).
Physical consequences of rHAT infection
It was estimated that 26 (40%) of the treated rHAT pa-
tients complained of pain after melarsoprol treatment.
Common reported side-effects after treatment included
muscle pain (89%), headache and intermittent fever
(n = 60, 93%), sleeping disorder (n = 42, 65%), loss of
weight and appetite (n = 44, 68%), nerve pain similar to
the feeling of heat (n = 56, 88%), back pain (n = 57, 89%)
and swelling in parts of the body (n = 11, 17%), especially
in the hands and feet, and lymph node enlargement. These
effects prevented full recovery that would allow them to
do their usual work.
Most patients who recovered from second stage
rHAT (n = 45, 70%) reported amnesia and claimed to
be stigmatized. The condition was reported as worse
among the school going children. One head teacher
reported:
“I don’t know what makes some of the pupils not to be
able to concentrate after being absent from school for
so long, they end up being worse than before. I am not
aware that sleeping sickness can have such devastating
consequences to the patient” (Head Teacher).
Physical deformities were observed in several rHAT
patients (Fig. 3) which tended to become permanent
disabilities. In a personal interview with a female pa-
tient who was still in hospital and had physical dis-
abilities, she mentioned that she believed the
disability was associated with melarsoprol treatment.
She further mentioned that the disability resulted in
her loss of self-esteem. It was also established during
focus group discussions that deformities had a strong
social impact on women because of loss of self-
esteem as they felt that they were no longer attractive
to the opposite sex.
Discussion
This study is the first to assess the economic and social
consequences of rHAT at the household level in endemic
areas in Zambia. It has used an innovative approach in
tracing the experience of patients from initial infection
through treatment pathways and losses of income.
Various short- and long-term effects on livelihood and
coping strategies including physical and mental health
effects on patients and affected community members
were analysed.
There have been sporadic cases of rHAT reported in
all the three provinces of Zambia included in this study
[27, 29] where they present a significant burden on the
household and the community. Patients incurred large
costs relating to treatment, both direct and indirect. Of
the 33 households who spent cash on treatment, the
average spend was equivalent to 4.5 months of house-
hold cash income. This places a large financial burden
on top of the loss of household income through ill
health. Interestingly, only three out of 19 (16%) female
cases spent money as against 30 out of 45 males (67%).
The average spend for those patients who spent money
on treatment was also less for female patients (US$ 84)
compared to males (US$ 172). Costs were mostly
centred on seeking treatment and hospitalisation. This
money was used to purchase drugs for self-medication,
for seeking treatment from traditional healers and for
seeking treatment in private health care institutions. The
costs described here are similar to those reported by
Lutumba et al. [19].
Transport costs associated with seeking care for a
rHAT patient were high. Of those patients spending
money on transport to seek treatment, the average
amount spent was US$ 99.3, a significant disincentive
for seeking appropriate medical care. A patient would
have to make several repeat visits on different occasions
before being correctly diagnosed with the disease, sug-
gesting that methods for diagnosing rHAT were ineffec-
tive. In particular, patients seeking care from traditional
healers and other pharmaceutical places for diagnosis
and treatment were not provided with the correct diag-
nosis or medication which delayed their presentation at
health centres. This finding is similar to Matemba et al.
[15] who reported that rHAT drugs were not readily
available and evidence showed that people often sought
basic health care services from more than one place.
The DALYs determined in this study were high
since the majority of the rHAT cases, 45 (70%), were
second stage. This observation is in line with a study
in Uganda in which delays in seeking treatment and
correct diagnosis increased the burden of the disease
Fig. 3 Deformed hands of a recovered rHAT patient
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[12; 16]. However the findings in our study did not
account for under-reporting as described by Fèvre et
al. [16] and Matemba et al. [15], the latter finding
that the high DALYs found in Tanzania’s Urambo dis-
trict was due to under-reporting. The high level of
second stage rHAT cases can be partly attributed to
delays in health-seeking treatment and cases being
initially misdiagnosed, indicative of failure to recog-
nise the disease by health workers and/or lack of ac-
tive surveillance for rHAT in affected areas [12; 13].
There was a notable difference in the number of
cases identified from 2004 to 2012 when a purely
passive surveillance method was used, compared with
2013–2014 when a more active surveillance method
was employed. An average of three cases per year was
diagnosed between 2004 and 2012, increasing to 14 in
2013 and 23 in 2014. This represents an increase of
nearly eight-fold and suggests there is a high level of
under-reporting. The likelihood of this being the case
is reinforced by the high proportion of second stage
patients [16]. It is also possible the higher incidence
in 2013–2014 could be due to an outbreak, with 17
cases being identified in Mpika District, but this is
considered to be less likely.
Many patients preferred to self-medicate and/or seek
treatment from traditional healers until they became
very ill, also contributing to late diagnoses. In agreement
with Odiit et al. [12], the average period of delay for a
rHAT case to attend a health care centre was two to
three months and patients would be receiving treatment
for a month. At the time of definitive rHAT diagnosis,
the patient would have been showing symptoms of the
disease for an average of 61 days and would then require
hospitalization for an average of 34 days. Matemba et al.
[15] reported that nearly three out of four cases of HAT
were presented to health facilities in late stage of the
disease in Urambo, Tanzania, and almost all of these
patients, 63 (98%), were presented passively. The
chances of treatment failure are higher at this stage and
treatment itself can result in death. Late stage pres-
entation has serious consequences, including a re-
duced chance of complete cure and increased risk of
drug-associated adverse effects or disabilities. The
mortality rate reported in the present study (12.5%)
was higher than expected after treatment with mela-
soprol (3–5%), and may be an under-estimate as
some patients may have died after the study con-
cluded. This suggests that accurate and timely diag-
nosis, vital for treatment success, was not achieved
by rural Zambian health systems during the period
of study. Delayed diagnosis also raises the risk of the
tsetse vectors picking up the infection when feeding
on an infected person and then transmitting the disease
to other people.
This study also found that HAT cases and mortality
rates were higher among males than females (Table 4),
with many of the affected men at the peak of their
productive life [19]. The tendency of rHAT to affect pro-
ductive adults is reflected in the increased DALY burden
when age-weighting is applied. Adolescent men com-
monly become heads of household and hence get ac-
tively involved in either agricultural activities and/or
hunting (poaching) in an attempt to provide food to the
family. These activities predispose individuals to a higher
risk of tsetse fly bites, and are mainly restricted to men.
Although this explanation for an incerased risk of con-
tracting rHAT is plausible, there are other factors which
influence the detection of female cases. During the
period from 2004 to 2012 when only passive case detec-
tion was used, the proportion of female cases was only
15%. In contrast, when more active case detection
methods were employed in 2013 the proportion in-
creased to 26%, and this increased further to 47% in
2014. This observation provides strong evidence that
under the passive system women are less likely to be
diagnosed and treated for rHAT. Combined with the
observation that female patients spent much less on
treatment, this suggests that this vulnerable group would
benefit from targeted health care and surveillance.
An important component of this study was the evalu-
ation of the impact of long-term disabilities on the bur-
den of rHAT. Long-term disabilities were common in
this patient cohort and are not accounted for in standard
HAT DALY calculations. The impact was significant
with the number of DALYs increasing by between 44%
and 50%, depending on whether age-weighting or dis-
counting was applied or not (Table 5). Being a life-long
effect they are much more affected by discounting than
calculations without their inclusion. In the standard
DALY calculation the vast majority of DALYs result from
YLL, as is expected for a disease with a high level of
mortality. As a proportion of the total DALYs, the YLDs
for the standard calculation were 6% of the total, and
10% of the discounted figures. However, when long-term
disabilities were included the proportion of DALYs due
to YLD increased to 37%. This represents an increase by
a factor of more than eight (undiscounted numbers) and
five (discounted numbers). There is a possibility that
long-term disabilities would have resulted in premature
death, but this is not included in the calculation as cases
could not be followed for life and there was no basis for
guessing. For this reason, assuming lifetime of disability
is a ‘conservative’ estimate in the sense that it makes the
DALY estimate lower rather than higher.
This study indicated that the social consequences of
HAT were misunderstanding, stigma, school dropout,
pain, amnesia and disability. Acquired muscular and nerve
deformity had a greater effect on female cases who often
Mwiinde et al. Infectious Diseases of Poverty  (2017) 6:150 Page 11 of 13
lost self-esteem. Kibona [39] also found that at both com-
munity and family levels, stigmatisation, mental confusion,
personality and behaviour changes (often characterized by
central nervous system involvement in late-stage disease)
could lead to school drop-outs, mortality, divorce and
break-up of relationships, and present an unfavourable
climate for bringing up children. Mental confusion/
amnesia caused the victims not to associate with
friends, while pain made the victims stay home in
most cases, depriving them of a social life. Stigma
resulted from low levels of awareness among commu-
nity members, while mental confusion may be a side
effect of both late stage disease damage or a conse-
quence of melarsoprol treatment, which is associated
with high toxicity [40]. While less toxic drug regimes
have been adopted for gHAT, for rHAT, melarsoprol
remains the only option [40].
Mental confusion/amnesia and pain underlie the high
DALY burden suffered at individual, family and commu-
nity levels in the areas of study. In addition to the direct
physical and mental burden it places on an individual, it
also deprives them of opportunities (such as education)
and results in loss of personal income and friends. This
is in concordance with the findings of WHO [41] who
reported that mental and behavioural disorders account
for 17.6% of all YLDs in Africa. Some can last for a few
weeks or months while others may last a lifetime, some
are not discernible except by scrutiny while others are
impossible to hide even from a casual observer.
The lack of reliable data on the occurrence and
outcome of infection for rHAT together with late
presentation complicates treatment and disease prog-
nosis. Moreover, limited awareness among community
members and lack of prevention programmes result
in a high disease burden and DALY for rHAT in rural
communities. Poor diagnostic capacity of the local
health system, specific therapeutic beliefs and prac-
tices, and the reluctance of patients to spend money
on treatment until the illness becomes debilitating
contributed to the high number of patients seeking
health care in late stages of disease. As a neglected
disease, analysis of the burden of rHAT on patient
and households in specific geographical foci can help
stimulate resource mobilisation for prevention and
control programmes at a local and national level.
Assessing the social and economic impacts of a
neglected disease outbreak can help to contextualise
the importance of prevention both to the affected
population and the costs of outbreak mitigation stra-
tegies funded by governments and donors.
Conclusions
rHAT is a disease that emerges out of poverty both in
terms of transmission dynamics and clinical outcomes,
while simultaneously perpetuating and reinforcing a
state of poverty among affected households. The disease
impacts households on multiple levels, including in areas
of income generation, agriculture and food security, chil-
dren’s education and long-term health consequences
such as acquired muscular, nerve deformity and mental
health (amnesia). At an individual level, the disease
causes loss of self-esteem due to being stigmatised
resulting from the acquired long-term physical and
mental disabilities. Assessing the social and economic
impacts of rHAT can help to contextualise the import-
ance of prevention both to the affected population and
the costs of outbreak mitigation strategies funded by
governments and donors. An evaluation of the impact of
long-term disabilities should be considered in future
studies on the burden of rHAT.
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